Hospitals Can't See Inside AI Tools — AHA Tells FDA
OVERVIEWThe American Hospital Association urged the FDA to hold AI developers primarily responsible for safety monitoring, arguing that hospitals lack technical visibility and resources to evaluate AI medical device performance independently. The AHA letter highlights a critical governance gap: hospitals are expected to implement and monitor AI tools but lack the technical infrastructure, expertise, and access to model internals necessary for meaningful oversight. This creates a liability and accountability vacuum where neither hospitals nor vendors have clear responsibility for detecting and responding to AI failures. ---
Subscribe to read full wiki analysis
Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.
View Plans & SubscribeNew users get a 7-day trial — no credit card required.